Haff disease medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 6: | Line 6: | ||
==Medical therapy== | ==Medical therapy== | ||
==== Management of Rhabdomyolysis ==== | ====Management of Rhabdomyolysis==== | ||
The goal of rhabdomyolysis is adequate fluid hydration with normal isotonic saline to prevent acute kidney injury. Urine output of 200 to 300 mL/h should be maintained with daily serial monitoring of CPK level for to document a downward trend. In case of fluid overload from aggressive fluid resuscitation, loop diuretics may be considered.<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref> In severe cases with CPK level > 30,000 IU/L, alkalization of the urine with bicarbonate can be considered.<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref><ref name="pmid31843046">{{cite journal| author=Pei P, Li XY, Lu SS, Liu Z, Wang R, Lu XC | display-authors=etal| title=The Emergence, Epidemiology, and Etiology of Haff Disease. | journal=Biomed Environ Sci | year= 2019 | volume= 32 | issue= 10 | pages= 769-778 | pmid=31843046 | doi=10.3967/bes2019.096 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31843046 }} </ref> | The goal of rhabdomyolysis is adequate fluid hydration with normal isotonic saline to prevent acute kidney injury. Urine output of 200 to 300 mL/h should be maintained with daily serial monitoring of CPK level for to document a downward trend. In case of fluid overload from aggressive fluid resuscitation, loop diuretics may be considered.<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref> In severe cases with CPK level > 30,000 IU/L, alkalization of the urine with bicarbonate can be considered.<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref><ref name="pmid31843046">{{cite journal| author=Pei P, Li XY, Lu SS, Liu Z, Wang R, Lu XC | display-authors=etal| title=The Emergence, Epidemiology, and Etiology of Haff Disease. | journal=Biomed Environ Sci | year= 2019 | volume= 32 | issue= 10 | pages= 769-778 | pmid=31843046 | doi=10.3967/bes2019.096 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=31843046 }} </ref> | ||
<br /> | |||
==== Management of Electrolytes Abnormalities ==== | |||
Rhabdomyolysis is associated with hyperkalemia and hypocalcemia.<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref> | |||
===== Hyperkalemia<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref> ===== | |||
* '''Potassium levels less than 6 mEq/L without EKG changes:''' managed with potassium binders, and use of bicarbonate in fluids | |||
* '''Potassium levels 6 mEq/L or above with or without EKG changes:''' ampule of D50 followed by zero units of regular insulin, and IV sodium bicarbonate. | |||
===== Hypocalcemia<ref name="pmid28846335">{{cite journal| author=| title=StatPearls | journal= | year= 2022 | volume= | issue= | pages= | pmid=28846335 | doi= | pmc= | url= }} </ref> ===== | |||
* '''Symptomatic hypocalcemia:''' should be treated with IV calcium gluconate.<br /> | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 06:21, 23 April 2022
|
Haff disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Haff disease medical therapy On the Web |
|
American Roentgen Ray Society Images of Haff disease medical therapy |
|
Risk calculators and risk factors for Haff disease medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: M. Hassan, M.B.B.S
Overview
Medical therapy
Management of Rhabdomyolysis
The goal of rhabdomyolysis is adequate fluid hydration with normal isotonic saline to prevent acute kidney injury. Urine output of 200 to 300 mL/h should be maintained with daily serial monitoring of CPK level for to document a downward trend. In case of fluid overload from aggressive fluid resuscitation, loop diuretics may be considered.[1] In severe cases with CPK level > 30,000 IU/L, alkalization of the urine with bicarbonate can be considered.[1][2]
Management of Electrolytes Abnormalities
Rhabdomyolysis is associated with hyperkalemia and hypocalcemia.[1]
Hyperkalemia[1]
- Potassium levels less than 6 mEq/L without EKG changes: managed with potassium binders, and use of bicarbonate in fluids
- Potassium levels 6 mEq/L or above with or without EKG changes: ampule of D50 followed by zero units of regular insulin, and IV sodium bicarbonate.
Hypocalcemia[1]
- Symptomatic hypocalcemia: should be treated with IV calcium gluconate.